Drug Trial Radar · NCT02456038
Safety and Efficacy of Asfotase Alfa in Patients With Hypophosphatasia (HPP)
Last checked: Nov 20, 2026Latest source record: Mar 31, 2016 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
13
Actual
Start
Aug 2014
Primary completion
Jul 2015
Study completion Jul 2015
Sponsor
- Lead sponsor
- Translational Research Center for Medical Innovation, Kobe, Hyogo, JapanAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Osaka University Graduate School of Medicine
- First posted
- May 28, 2015
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The aim of this study is to assess safety and efficacy of Asfotase Alfa (ALXN1215) in patients with hypophosphatasia
Conditions
- Hypophosphatasia
Interventions
Asfotase Alfa (ALXN1215)Drug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of subjects with Adverse Events as an assessment of the Safety of repeated subcutaneous (SC) injections of asfotase alfaTime frame: Up to 50 months or until regulatory approval
Locations
12 sites in 1 country. Site status is shown where the registry gives one.
Kurume University Hospital
Kurume, Fukuoka, Japan
National Hospital Organization Nagara Medical Center
Gifu, Gifu, Japan
Hiroshima University Hospital
Hiroshima, Hiroshima, Japan
Hokkaido University Hospital
Sapporo, Hokkaido-prefecture, Japan
Tohoku University Hospital
Sendai, Miyagi, Japan
Niigata University Medical & Dental Hospital
Niigata, Niigata, Japan
Osaka Medical Center and Research Institute for Maternal and Child Health
Izumi, Osaka, Japan
Osaka University Hospital
Suita, Osaka, Japan
Saitama Children's Medical Center
Saitama, Saitama, Japan
Hamamatsu University Hospital
Hamamatsu, Shizuoka, Japan
Nippon Medical School Hospital
Bunkyo-ku, Tokyo, Japan
Showa General Hospital
Kodaira, Tokyo, Japan
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.